Invesco’s Alto Neuroscience ANRO Stock Holding History

Invesco’s Portfolio ANRO Stock Details ANRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-31,031	Closed	-$67K	–	3896
2025 Q1	$67K	Buy	+31,031	New	+$111K	﹤0.01%	3675

Other funds holding ANRO

AWG

Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

7IH

72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Invesco's ANRO Position: Q2 2025 in Review

Invesco sold out of Alto Neuroscience (ANRO) in Q2 2025, closing a stake of 31,031 shares — an estimated $67K sold.

Invesco first reported a position in ANRO in Q1 2025 and held it in 1 quarter. The position peaked at $67K in Q1 2025. 80 funds tracked by Wall St. Rank hold ANRO as of Q2 2025.

Invesco reported no remaining Alto Neuroscience position as of Q2 2025 after selling out during the quarter.
Invesco sold 31,031 Alto Neuroscience shares in Q2 2025, an estimated $67K.
Invesco first reported a position in Alto Neuroscience in Q1 2025 and held it in 1 quarter.
Invesco's Alto Neuroscience position peaked at $67K in Q1 2025.
80 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2025.

Based on Invesco's 13F filing for Q2 2025, filed 13 Aug 2025.